FDA Inspection
Bi-Coastal Pharma InternationalFDA Inspection 1161078 - Bi-Coastal Pharma International - January 14, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
This FDA Inspection record concerns Bi-Coastal Pharma International, with an inspection on January 14, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
Open in Dashboard
ID · 22b8b76f-f16b-4d9d-af96-e43b2e232e7a
Violation Codes5
21 CFR 211.166(a)21 CFR 211.198(a)21 CFR 211.198(b)(2)21 CFR 211.22(d)21 CFR 211.25(b)
Full citation text and observation details available on the Dashboard.